Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,968 | 21,610 | N/A | 15,840 | 20,246 |
| Receivables | 190 | 542 | N/A | 511 | 258 |
| TOTAL | $21,158 | $22,152 | $N/A | $16,351 | $20,504 |
| Non-Current Assets | |||||
| PPE Net | 10,122 | 9,857 | N/A | 8,650 | 7,537 |
| Other Non-Current Assets | 2,213 | 2,263 | 0 | 2,356 | 197 |
| TOTAL | $12,335 | $12,120 | $N/A | $11,006 | $7,734 |
| Total Assets | $33,493 | $34,272 | $N/A | $27,357 | $28,238 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,285 | 681 | 0 | 4,550 | 5,816 |
| TOTAL | $5,486 | $881 | $N/A | $4,736 | $5,816 |
| Non-Current Liabilities | |||||
| Long Term Debt | 35,816 | 31,118 | N/A | 24,447 | 25,176 |
| Other Non-Current Liabilities | 11,014 | 8,141 | 0 | 6,596 | 5,574 |
| TOTAL | $46,830 | $39,259 | $N/A | $31,043 | $30,750 |
| Total Liabilities | $52,316 | $40,140 | $N/A | $35,780 | $36,566 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 114 | N/A | N/A | N/A | N/A |
| Retained earnings | -92,690 | -79,644 | N/A | -57,979 | -56,335 |
| TOTAL | $-18,823 | $-5,868 | $N/A | $-8,423 | $-8,328 |
| Total Liabilities And Equity | $33,493 | $34,272 | $0 | $27,357 | $28,238 |